leadf
logo-loader
viewFrontier IP Group PLC

Frontier IP Group teams up with University of Cambridge to tackle gum disease

Frontier IP Group PLC's (LON:FIPP) Neil Crabb discusses with Proactive London's Andrew Scott a new joint project between themselves and the University of Cambridge to tackle gum disease. The study's received a £52,891 grant from the National Biofilms Innovation Centre (NBIC). The proof-of-concept award will support an eight-month project to explore the potential of origami-like DNA nanostructures to disrupt the dental plaque biofilms formed by P.gingivalis, the bacterium responsible for gum disease.

Quick facts: Frontier IP Group PLC

Price: 69 GBX

AIM:FIPP
Market: AIM
Market Cap: £37.95 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Morning Report: FTSE 100 continues climb as US markets rally

Headlines from the Proactive UK newsroom. The FTSE 100 opened higher defying predictions of a pullback after the 3% gain seen Tuesday. London’s blue-chip index added 46 to 6,288 after US markets rose overnight. UK inflation has dropped to 0.5% after fuel prices fell by a record amount in...

on 17/6/20

2 min read